Cipla gets nod for generic version of Shire’s Firazyr

Pharma major Cipla has announced that the company has received the final approval for its Abbreviated New Drug Application (ANDA) for Icatibant Injectable 30mg/3mL from the United States Food and Drug Administration (US FDA).

Cipla’s Icatibant Injectable Pre-Filled Syringe 30mg/3mL is AP-rated generic version of Shire’s Firazyr.The purpose of the Icatibant injection is for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.

  • Related Posts

    NPPA fixes prices of 30 drugs including Vitamin D3, calcium supplements

    The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 30 drug formulations, including Vitamin D3 oral solution, calcium and vitamin supplements, anti-diabetic medicines, cardiovascular drugs and immunosuppressant…

    Maharashtra FDA seizes ₹73 lakh worth of medicines in crackdown on misleading health claims in ads

    Maharashtra’s Food and Drug Administration has confiscated medicines worth more than ₹73 lakh, including Patanjali-linked products valued at over ₹51 lakh, in a statewide drive against misleading advertisements and misbranded…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    NPPA fixes prices of 30 drugs including Vitamin D3, calcium supplements

    NPPA fixes prices of 30 drugs including Vitamin D3, calcium supplements

    Maharashtra FDA seizes ₹73 lakh worth of medicines in crackdown on misleading health claims in ads

    Maharashtra FDA seizes ₹73 lakh worth of medicines in crackdown on misleading health claims in ads

    Industry asks NPPA to implement SOTS Scheme to resolve pending litigations

    Industry asks NPPA to implement SOTS Scheme to resolve pending litigations

    A Non- Smoker Smoking Hot Spouse needed for Actress Neetu Chandra

    A Non- Smoker Smoking Hot Spouse needed for Actress Neetu Chandra

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad